样式: 排序: IF: - GO 导出 标记为已读
-
Kinetic Characterization of Estradiol Glucuronidation by Liver Microsomes and Expressed UGT Enzymes: The Effects of Organic Solvents Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-03-12 Caimei Wu, Meixue Luo, Dihao Xie, Simin Zhong, Jiahao Xu, Danyi Lu
-
Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-03-10 Slobodan M. Janković, Snežana V. Janković
The calcitonin gene-related peptide transmission was the target for recent development of drugs that effectively prevent attacks of both episodic and chronic migraine. The aim of this narrative review was to offer deeper insight into pharmacokinetics of monoclonal antibodies approved for prevention of migraine attacks. For this narrative review, relevant literature was searched for in MEDLINE and Google
-
Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Drug Interactions Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-03-08 Slobodan M. Janković, Snežana V. Janković
Calcitonin gene-related peptide neurotransmission was the target for recent development of monoclonal antibodies that effectively prevent attacks of both episodic and chronic migraine. The aim of this narrative review was to offer deeper insight into drug-drug, drug-food and drug-disease interactions of monoclonal antibodies approved for prevention of migraine attacks. For this narrative review, relevant
-
Predicting Pharmacokinetics of Drugs Using Artificial Intelligence Tools: A Systematic Review Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-03-08 Mahnaz Ahmadi, Bahareh Alizadeh, Seyed Mohammad Ayyoubzadeh, Mahdiye Abiyarghamsari
-
Safety, Tolerability, and Pharmacokinetics of the Monoamine Oxidase B Inhibitor, HEC122505, and its Major Metabolite After Single- and Multiple- Ascending Dose, and Food Effect Study in Healthy Chinese Subjects Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-03-06
Abstract Background and Objectives HEC122505 is a potent and selectively monoamine oxidase B inhibitor that is safe and well-tolerated in preclinical models of Parkinson’s disease. The objectives of single ascending dose and multiple dose pharmacokinetic trials of HEC122505 oral tablets were to determine the safety and tolerability of HEC122505, and to examine the food effect on the pharmacokinetic
-
Pharmacokinetic Study of Ultrasmall Superparamagnetic Iron Oxide Nanoparticles HY-088 in Rats Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-02-23 Xin Song, Minglan Zheng, Heping Hu, Lei Chen, Shuzhe Wang, Zhao Ding, Guangyi Fu, Luyao Sun, Liyuan Zhao, Ling Zhang, Bohua Xu, Yunliang Qiu
-
Pharmacokinetics, Safety Profile, and Tolerability of Tetramethylpyrazine Nitrone Tablets After Single and Multiple Ascending Doses in Healthy Chinese Volunteers Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-02-21
Abstract Background and Objectives Tetramethylpyrazine nitrone (TBN) is a novel tetramethylpyrazine derivative armed with a strong free radical scavenging nitrone moiety. This study aims to evaluate the pharmacokinetics, safety profile, and tolerability of TBN tablets after a single ascending dose (SAD) and multiple ascending doses (MAD) in healthy Chinese volunteers. Methods This phase I, single-center
-
Pharmacokinetics of Dasatinib in Rats: a Potential Food–Drug Interaction with Naringenin Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-02-20 Mohammad Raish, Ajaz Ahmad, Badr Abdul Karim, Yousef A. Bin Jardan, Abdul Ahad, Muzaffar Iqbal, Khalid M. Alkharfy, Fahad I. Al-Jenoobi, Omer Mansour Mohammed
-
Pharmacokinetic–Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-02-17 Lars L. F. G. Valke, Michael E. Cloesmeijer, Hassan Mansouritorghabeh, Wideke Barteling, Nicole M. A. Blijlevens, Marjon H. Cnossen, Ron A. A. Mathôt, Saskia E. M. Schols, Waander L. van Heerde
-
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Ocedurenone (KBP-5074) in Individuals with Moderate Hepatic Impairment Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-02-08 James McCabe, Jay Zhang, Fred Yang, Vincent Benn
-
Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-02-08 Marta Colaneri, Camilla Genovese, Pietro Valsecchi, Matteo Calia, Dario Cattaneo, Andrea Gori, Raffaele Bruno, Elena Seminari
Intravenous drug users (IVDUs) face heightened susceptibility to life-threatening gram-positive bacterial infections, particularly methicillin-resistant Staphylococcus aureus (MRSA). While the standard antibiotic dosing strategies for special patients, such as obese or critically ill individuals, are known to be inadequate, raising concerns about treatment efficacy, a similar sort of understanding
-
Influence of Bile Acids on Clindamycin Hydrochloride Skin Permeability: In Vitro and In Silico Preliminary Study Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-02-08
Abstract Background and Objective Topical clindamycin formulations are widely used in clinical practice, but poor bioavailability and restricted skin penetration considerably limit their therapeutic efficacy. Penetration enhancement represents a promising and rational strategy to overcome the drawbacks of conventional topical pharmaceutical formulations. We aim to assess the influence of cholic acid
-
Improved Pharmacokinetic and Pharmacodynamic Profile of Deuterium-Reinforced Tricyclic Antidepressants Doxepin, Dosulepin, and Clomipramine in Animal Models Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2024-01-03 Shreyash Moharir, Likhit Akotkar, Urmila Aswar, Dileep Kumar, Bapu Gawade, Kavita Pal, Rajesh Rane
-
Pharmacokinetic Interaction Between Imatinib and Metformin in Rats Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-12-23
Abstract Background and Objective Imatinib is primarily transported into the liver by organic cation transporter 1 (OCT1), organic anion transporting polypeptide 1B3 (OATP1B3), and novel organic cation transporter 2 (OCTN2), which is the first step in the metabolic and elimination of imatinib. Patients taking imatinib may concurrently take metformin, a substrate for OCT1. Drug-drug interactions (DDI)
-
Novel Techniques and Models for Studying the Role of the Gut Microbiota in Drug Metabolism Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-12-21 Jianling Tan, Bingxuan Fu, Xiaojie Zhao, Ling Ye
-
Pharmacokinetics of Long-Acting Methylphenidate: Formulation Differences, Bioequivalence, Interchangeability Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-12-21 Mostafa Moharram, Tony Kiang
-
Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-12-20 Felicitas Stoll, Antje Blank, Gerd Mikus, David Czock, Johanna Weiss, Marleen J. Meyer-Tönnies, Katja S. Gümüs, Mladen Tzvetkov, Jürgen Burhenne, Walter E. Haefeli
-
Comparative Pharmacokinetic Study of Rhubarb Anthraquinones in Normal and Nonalcoholic Fatty Liver Disease Rats Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-12-19 Fang Zhang, Rui Wu, Yanfang Liu, Shu Dai, Xinyan Xue, Xiaohong Gong, Yunxia Li
-
Development, Physicochemical Characteristics and Pharmacokinetics of a New Sustained-Release Bilayer Tablet Formulation of Tramadol with an Immediate-Release Component for Twice-Daily Administration Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-12-08 Naoki Ishitsubo, Shinji Oguro, Hirotoshi Shimahashi, Masato Kawanishi, Takeshi Adachi, Kenji Mitsuda, Nobuyuki Ishibashi
-
Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-12-03 Stefanie Reif, Marcus-Hillert Schultze-Mosgau, Anna Engelen, Isabel Piel, Karsten Denner, Ad Roffel, Renger Tiessen, Stefan Klein, Klaus Francke, Antje Rottmann
-
Pharmacokinetic Parameters of Recombinant Human Cyclophilin A in Mice Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-12-01 Anastasiia Kalinina, Elena Grigorieva, Anna Smirnova, Dmitry Kazansky, Ludmila Khromykh
-
Ticagrelor Steady-State Trough Concentration in Chinese Patients Undergoing Percutaneous Coronary Intervention Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-11-24 ShaoJun Zheng, Qiong Jie, NaiDong Chen, XiJing Chen, YuBing Zhu
-
Pharmacokinetics of Imatinib Mesylate and Development of Limited Sampling Strategies for Estimating the Area under the Concentration–Time Curve of Imatinib Mesylate in Palestinian Patients with Chronic Myeloid Leukemia Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-11-25 Deema Hilmi Adawi, Nadia Ben Fredj, Ahmad Al-barghouthi, Ichrack Dridi, Mustafa Lubada, Mohammad Manasra, Karim Aouam
-
Pharmacokinetics of 4-Hydroxybenzaldehyde in Normal and Cerebral Ischemia–Reperfusion Injury Rats Based on Microdialysis Technique Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-11-24 Chunping Xu, Jin Feng, Hang Sun, Mingli Yan, Qian Yang, Xiaonan Zhou, Jianguang Yang, Fangyan He, Qing Lin
-
Distribution, Metabolism, and Excretion of Cenobamate in Adult, Fetal, Neonatal, and Lactating Rats Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-11-03 Jairam Palamanda, Kelli J. Glenn, Susan M. Melnick
-
Neural Network Models for Predicting Solubility and Metabolism Class of Drugs in the Biopharmaceutics Drug Disposition Classification System (BDDCS) Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-10-21 Aryan Ashrafi, Kiarash Teimouri, Farnaz Aghazadeh, Ali Shayanfar
-
Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug–Drug Interaction Study in Rats Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-10-13 Shyamala Mudavath, Dongamanti Ashok
-
Pharmacokinetics, Mass Balance and Metabolism of [14C]HSK21542, a Novel Kappa Opioid Receptor Agonist, in Humans Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-10-13 Jin-jie Yuan, Yi-cong Bian, Sheng Ma, Wei Chen, Feng-yi Zhang, Hua Zhang, Li-yan Miao
-
The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-10-10 Rahmat Hidayat, Mahmoud A. El-Ghiaty, Sherif M. Shoieb, Mohammed A. Alqahtani, Ayman O. S. El-Kadi
-
The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug–Drug Interaction in Healthy Participants Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-10-07 Rose Marino, Louise Dube, Julien Ogier, Kim-Hanh Le Quan Sang
-
Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin®) in Patients with Non-squamous Non-small Cell Lung Cancer Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-10-04 Joel S. Owen, Russell J. Rackley, Matthew A. Hummel, Stefan Roepcke, Hannah Huang, Mark Liu, Tazeen A. Idris, Sundara Moorthi Nainar Murugesan, Ashwani Marwah, Subramanian Loganathan, Gopinath Ranganna, Abhijit Barve, Cornelius F. Waller, Mark A. Socinski
-
Use of Clearance Concepts to Simulate Impact of Interleukin-6 on Drug Elimination Governed by Cytochromes P450 3A4 and Glomerular Filtration Rate. Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-10-04 Xiang Chen,Guo Yu,Guo-Fu Li
-
Pharmacokinetics and Safety of Long-Acting Release Formulations of Pasireotide (SOM230) in a Male Population Who Are Hyperendemic Hepatitis B/C and Chronic Kidney Disease: An Open-Label, Phase I Study Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-09-26 Chun-Jui Huang, Chieh-Hua Lu, Kuang-Chung Shih
-
Unraveling the Effects of Acute Inflammation on Pharmacokinetics: A Model-Based Analysis Focusing on Renal Glomerular Filtration Rate and Cytochrome P450 3A4-Mediated Metabolism Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-09-15 Feiyan Liu, Linda B. S. Aulin, Martijn L. Manson, Elke H. J. Krekels, J. G. Coen van Hasselt
-
Population Pharmacokinetic Analysis of Vancomycin in Patients with Solid or Hematological Malignancy in Relation to the Quick Sequential Organ Failure Assessment Scores Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-09-11 Yasumasa Tsuda, Masahiro Takahashi, Fumiya Watanabe, Kazumi Goto, Hirotoshi Echizen
-
Effect of Moderate Malnutrition on the Pharmacokinetics of Etoposide and Vincristine in Freshly Weaned Rats Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-09-12 Megha Garg, Khushboo Gandhi, Shraddha Mahesh Jadhav, Murari Gurjar, Vikram Gota
-
Comparison of In Vitro Corneal Permeation and In Vivo Ocular Bioavailability in Rabbits of Three Marketed Latanoprost Formulations Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-09-08 Laure Chauchat, Camille Guerin, Yulia Kaluzhny, Jean-Paul Renard
-
mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-09-01 Satyendra Prakash
-
Evaluating the Pharmacokinetics of Fentanyl in the Brain Extracellular Fluid, Saliva, Urine, and Plasma of Newborns from Transplacental Exposure from Parturient Mothers Dosed with Epidural Fentanyl Utilizing PBPK Modeling Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-08-10 Mo’tasem M. Alsmadi
-
Application of Allometric Scaling and Salisbury Rule for the Prediction of Antimalarial Drugs for First-in-Pediatric Dose Selection Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-08-11 Iftekhar Mahmood
Background In pediatric drug development, the selection of first-in-pediatric dose is of immense importance. Generally, the pharmacokinetic information and a safe and efficacious dose of a drug in adults are already known and this information can then be used to select first-in-pediatric dose. The objective of this study was to predict the pediatric dose of antimalarial drugs and compare the predicted
-
First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-08-02 Tamas Shisha, Maximilian G. Posch, Jeanette Lehmann, Roland Feifel, Tobias Junt, Stuart Hawtin, Jens Schuemann, Alexandre Avrameas, Rambabu Danekula, Patrycja Misiolek, Richard Siegel, Peter Gergely
-
A Quantitative Prediction Method for the Human Pharmacokinetics of Fc-Fusion Proteins Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-08-02 Miki Yokoyama, Eiko Suzuki, Masataka Oitate, Nobuaki Watanabe
-
Preclinical Pharmacokinetics and in vitro Metabolism of FHND5071, a Novel Selective RET Kinase Inhibitor Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-08-02 Yiran Han, Tiantian Wen, Jia Wang, Jinmiao Shi, Yongqiang Zhu
-
Nano Drug Delivery Strategies for an Oral Bioenhanced Quercetin Formulation Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-07-31 Esha S. Attar, Vanashree H. Chaudhari, Chaitanya G. Deokar, Sathish Dyawanapelly, Padma V. Devarajan
-
Dried Blood Spots—A Platform for Therapeutic Drug Monitoring (TDM) and Drug/Disease Response Monitoring (DRM) Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-07-26 Nur Nabihah Binte Zailani, Paul Chi-Lui Ho
-
Population Pharmacokinetic Modeling and Dose Optimization of Acetaminophen and its Metabolites Following Intravenous Infusion in Critically ill Adults Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-30 Kannan Sridharan, Mwila Mulubwa, Ali Mohamed Qader
-
Metabolism and Disposition of the Novel Oral Factor XIa Inhibitor Asundexian in Rats and in Humans Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-26 Isabel Piel, Anna Engelen, Dieter Lang, Simone I. Schulz, Michael Gerisch, Christine Brase, Wiebke Janssen, Lukas Fiebig, Stefan Heitmeier, Friederike Kanefendt
-
Monitoring Salivary Concentrations of Tedizolid and Linezolid Using Rats Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-27 Yuki Inoue, Yuki Sato, Hitoshi Kashiwagi, Shunsuke Nashimoto, Mitsuru Sugawara, Yoh Takekuma
-
Pharmacokinetics and Drug–Drug Interaction of Ocedurenone (KBP-5074) in vitro and in vivo Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-25 Ping Wang, Jinrong Liu, Xiaojuan Tan, Fred Yang, James McCabe, Jay Zhang
-
Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal Membrane Oxygenation (ECMO) Circuit Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-23 Angela V. Berry, Allison Conelius, Jason A. Gluck, David P. Nicolau, Joseph L. Kuti
-
Hydrolytic Metabolism of Withangulatin A Mediated by Serum Albumin Instead of Common Esterases in Plasma Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-21 Yu Zhuang, Yuxiao Wang, Ning Li, Haitao Meng, Zhiyu Li, Jianguang Luo, Zhixia Qiu
-
Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-19 Erin C. Berthold, Shyam H. Kamble, Siva Rama Raju Kanumuri, Michelle A. Kuntz, Alexandria S. Senetra, Yi-Hua Chiang, Lance R. McMahon, Christopher R. McCurdy, Abhisheak Sharma
-
Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot Study Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-15 Paul A. G. de Klaver, Ron J. Keizer, Rob ter Heine, Lisa Smits, Paul J. Boekema, Inge Kuntzel, Tiny Schaap, Annick de Vries, Karien Bloem, Theo Rispens, Frank Hoentjen, Luc J. J. Derijks
-
Management of Drug Interactions with Inducers: Onset and Disappearance of Induction on Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyltransferase 1A1 Substrates Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-06 Sara Bettonte, Mattia Berton, Felix Stader, Manuel Battegay, Catia Marzolini
-
Development of a 2D-QSAR Model for Tissue-to-Plasma Partition Coefficient Value with High Accuracy Using Machine Learning Method, Minimum Required Experimental Values, and Physicochemical Descriptors Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-02 Koichi Handa, Seishiro Sakamoto, Michiharu Kageyama, Takeshi Iijima
-
Re-examining Naloxone Pharmacokinetics After Intranasal and Intramuscular Administration Using the Finite Absorption Time Concept Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-06-02 Athanasios A. Tsekouras, Panos Macheras
-
Pharmacokinetic Study of 14C-Radiolabeled p-Boronophenylalanine (BPA) in Sorbitol Solution and the Treatment Outcome of BPA-Based Boron Neutron Capture Therapy on a Tumor-Bearing Mouse Model Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-05-18 Tsubasa Watanabe, Tomohiro Yoshikawa, Hiroki Tanaka, Yuko Kinashi, Genro Kashino, Shin-ichiro Masunaga, Toshimitsu Hayashi, Koki Uehara, Koji Ono, Minoru Suzuki
-
Clinical Pharmacokinetics of Radiopharmaceuticals from SPECT/CT Image Acquisition by Contouring in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Lu-177 DOTATATE (Lutathera®) Case Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-05-15 Anissa Barakat, Lore Santoro, Myrtille Vivien, Pierre-Olivier Kotzki, Emmanuel Deshayes, Sonia Khier
-
In Vitro Assessment of the Metabolic Stability of Two Novel Endomorphin-2 Analogs, CYX-5 and CYX-6, in Rat Liver Microsomes Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-05-12 Mohammad Zafar Imam, Sussan Ghassabian, Andy Kuo, Yunxin Cai, Yajuan Qin, Tingyou Li, Maree T. Smith
-
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions Eur J Drug Metab Pharmacokinet (IF 1.9) Pub Date : 2023-04-24 Sharoen Yu Ming Lim, Basel Al Bishtawi, Willone Lim